Cite
HARVARD Citation
Müller‐Wieland, D. et al. (2018). Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes. Diabetes, obesity & metabolism. 20 (11), pp. 2598-2607. [Online].